SIRT1 inhibits SREBP1 activity by deacetylating SREBP1, down‐regulates COX‐2 expression and consequently reduces the impact of obesity‐related inflammation on colon cancer.177. This evidence concerns the gene SREBF1 and colonic neoplasm.